DeepMed Research

THOMAS JEFFERSON UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1824-01-01

Employees: 10K

Market Cap: -

Website: http://www.jefferson.edu

Clinical Trials

A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer

Not Applicable

Recruiting

Conditions: Malignant Breast Neoplasm

Interventions: Procedure: Ultrasonography
Procedure: Automated Breast Ultrasound

First Posted Date: 2022-06-07

Last Posted Date: 2025-05-20

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 30

Registration Number: NCT05408260

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Opioid Reduction Toolkit Reduces Opioids Prescribed and Consumed

Phase 4

Suspended

Conditions: Pain
Opioid Abuse
Opioid Misuse

Interventions: Drug: Oxycodone

First Posted Date: 2022-05-05

Last Posted Date: 2024-04-22

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 159

Registration Number: NCT05363436

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Quantitative COVID-19 SARS-CoV-2 Antibody Pre and Post Cardiopulmonary Bypass

Completed

Conditions: Laboratory Assessment SARS-CoV-2 Antibody Levels Before and After Surgery for Patients Requiring Cardiopulmonary Bypass

First Posted Date: 2022-05-03

Last Posted Date: 2022-05-03

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 60

Registration Number: NCT05357885

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Reducing Anemia in Pregnancy in India: the RAPIDIRON Trial

Phase 4

Completed

Conditions: Infant, Low Birth Weight
Anemia of Pregnancy
Iron Deficiency Anemia

Interventions: Drug: Ferric carboxymaltose
Drug: Iron isomaltoside
Drug: Ferric Sulfate

First Posted Date: 2022-05-03

Last Posted Date: 2024-05-24

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 4368

Registration Number: NCT05358509

Locations: 🇮🇳
Sawai Man Singh Medical College, Jaipur, Rajasthan, India
🇮🇳
Jawaharlal Nehru Medical College, Belgaum, Karnataka, India
🇮🇳
Raichur Institute of Medical Sciences, Raichur, Karnataka, India

and more 1 locations

Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)

Phase 3

Recruiting

Conditions: Prostate Carcinoma

Interventions: Drug: Perflutren Lipid Microspheres
Procedure: Ultrasound

First Posted Date: 2022-04-20

Last Posted Date: 2025-05-20

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 70

Registration Number: NCT05336786

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
🇳🇱
Amsterdam University Medical Centers, Amsterdam, Netherlands

Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment

Phase 2

Recruiting

Conditions: Intrahepatic Cholangiocarcinoma

Interventions: Drug: Perflutren Protein-Type A Microspheres
Procedure: Contrast-Enhanced Ultrasound

First Posted Date: 2022-04-14

Last Posted Date: 2024-11-22

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 20

Registration Number: NCT05328167

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Toward Zero Prescribed Opioids for Outpatient General Surgery

Phase 4

Completed

Conditions: Opioid Misuse and Addiction
Pain

Interventions: Drug: Oxycodone
Behavioral: Zero Opioid Protocol

First Posted Date: 2022-04-14

Last Posted Date: 2023-06-05

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 129

Registration Number: NCT05327777

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Neoadjuvant Breast Cancer Time Restricted Eating

Not Applicable

Recruiting

Conditions: Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Breast Ductal Carcinoma in Situ
Invasive Breast Carcinoma
Anatomic Stage I Breast Cancer AJCC v8
HER2 Negative Breast Carcinoma
Hormone Receptor Positive Breast Carcinoma

Interventions: Other: Short-Term Fasting

First Posted Date: 2022-04-14

Last Posted Date: 2025-04-25

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 55

Registration Number: NCT05327608

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Diagnosing Compartment Syndrome With SHAPE vs Elastography

Phase 2

Completed

Conditions: Chronic Exertional Compartment Syndrome

Interventions: Drug: Definity

First Posted Date: 2022-02-21

Last Posted Date: 2023-12-12

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 15

Registration Number: NCT05247541

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Safety and Tolerability of Nitro for Radial Artery Dilation

Early Phase 1

Conditions: Artery; Dilatation

Interventions: Drug: Nitroglycerin ointment

First Posted Date: 2022-02-14

Last Posted Date: 2022-04-06

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 20

Registration Number: NCT05239013

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy